Titel

Merkliste
1 Ergebnisse

Table_2_Pegylated Liposomal Doxorubicin Versus Epirubicin a..:

Wenxian Hu (184393) ; Kezhen Lv (316611) ; Rongyue Teng (316624)...
https://figshare.com/articles/dataset/Table_2_Pegylated_Liposomal_Doxorubicin_Versus_Epirubicin_as_Adjuvant_Therapy_for_Stage_I_III_Breast_Cancer_XLSX/16642504. , 2021

Link: https://doi.org/10.3389/fgene.2021.746114.s002

RT Journal
T1 <Title>Table_2_Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I–III Breast Cancer.XLSX</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16642504&Exemplar=1&LAN=DE
				
A1 Wenxian Hu (184393)
A1 Kezhen Lv (316611)
A1 Rongyue Teng (316624)
A1 Jida Chen (9071972)
A1 Chenpu Xu (11454043)
A1 Lidan Jin (11454046)
A1 Yongxia Chen (424187)
A1 Wenhe Zhao (11454049)
YR 2021
K1 Genetics
K1 Genetic Engineering
K1 Biomarkers
K1 Developmental Genetics (incl. Sex Determination)
K1 Epigenetics (incl. Genome Methylation and Epigenomics)
K1 Gene Expression (incl. Microarray and other genome-wide approaches)
K1 Genome Structure and Regulation
K1 Genomics
K1 Genetically Modified Animals
K1 Livestock Cloning
K1 Gene and Molecular Therapy
K1 breast cancer
K1 pegylated liposomal doxorubicin
K1 epirubicin
K1 adjuvant therapy
K1 efficacy and toxicity
JF https://figshare.com/articles/dataset/Table_2_Pegylated_Liposomal_Doxorubicin_Versus_Epirubicin_as_Adjuvant_Therapy_for_Stage_I_III_Breast_Cancer_XLSX/16642504
LK http://dx.doi.org/https://doi.org/10.3389/fgene.2021.746114.s002
DO https://doi.org/10.3389/fgene.2021.746114.s002
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)